Literature DB >> 3932137

Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.

J N Thompson, J A Barr, N Collier, J Spencer, A Bush, L Cope, R J Gribble, J H Baron.   

Abstract

Gastric secretion was measured in nine patients with duodenal ulcer before, and after treatment for four weeks with omeprazole 20 mg or 40 mg daily. Basal acidity and acid output were affected variably by 20 mg, but inhibited totally by 40 mg daily. Sham feed stimulated acid output was reduced by 20 mg daily and completely inhibited by 40 mg daily. Maximal pentagastrin stimulated acid output was halved by 20 mg omeprazole daily and 84% inhibited by 40 mg daily. The reduction in acidity was always greater than the reduction of volume. Pepsin output after pentagastrin was little altered but with the reduced secretory volume pepsin concentrations were increased by both doses. The major cause of reduced aspirate acid output after omeprazole is decreased secretion of the primary acid component of the parietal cell by the proton pump H+K+ ATPase. Duodenogastric alkaline reflux is, however, markedly increased after omeprazole and is an additional factor in the resultant hypoacidity or even anacidity after this drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3932137      PMCID: PMC1432935          DOI: 10.1136/gut.26.10.1018

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Composition of the alkaline component of human gastric juice: effect of swallowed saliva and duodeno-gastric reflux.

Authors:  E T Okosdinossian; H A el-Munshid
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

2.  Pyloric reflux: a modification of the two-component hypothesis of gastric secretion.

Authors:  M Hobsley
Journal:  Clin Sci Mol Med       Date:  1974-08

3.  [The automatic determination of proteolytic activity of gastric juice].

Authors:  A M Cheret; S Bonfils
Journal:  Biol Gastroenterol (Paris)       Date:  1968

4.  Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans.

Authors:  L Olbe; U Haglund; R Leth; T Lind; C Cederberg; G Ekenved; B Elander; E Fellenius; P Lundborg; B Wallmark
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

5.  Duodenal reflux during insulin-stimulated secretion.

Authors:  R G Faber; R C Russell; C M Royston; P Whitfield; M Hobsley
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

6.  Effect of omeprazole on gastric secretion in H+,K+-ATPase and in pepsinogen-rich cell fractions from rabbit gastric mucosa.

Authors:  J Fryklund; B Wallmark; H Larsson; H F Helander
Journal:  Biochem Pharmacol       Date:  1984-01-15       Impact factor: 5.858

7.  Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.

Authors:  E Fellenius; T Berglindh; G Sachs; L Olbe; B Elander; S E Sjöstrand; B Wallmark
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

8.  Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion.

Authors:  J N Hunt; J L Smith; C L Jiang; L Kessler
Journal:  Dig Dis Sci       Date:  1983-10       Impact factor: 3.199

9.  Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.

Authors:  T Lind; C Cederberg; G Ekenved; U Haglund; L Olbe
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

10.  Effect of daily oral omeprazole on 24 hour intragastric acidity.

Authors:  R P Walt; M D Gomes; E C Wood; L H Logan; R E Pounder
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02
View more
  5 in total

1.  U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group.

Authors:  J E Valenzuela; R G Berlin; W J Snape; T L Johnson; B I Hirschowitz; J Colon-Pagan; R S Morse; J Petrozza; G M Van Deventer; A Cagliola
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).

Authors:  J H Baron; J Barr; J Batten; R Sidebotham; J Spencer
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

3.  Influence of chronic omeprazole treatment on gastric endocrine function.

Authors:  H Koop; H Schwarting; A Knorr-Marin; C Willhardt; T Möser; R Arnold
Journal:  Klin Wochenschr       Date:  1987-02-16

Review 4.  Clinical pharmacology of omeprazole.

Authors:  C W Howden
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 5.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.